Status:
COMPLETED
Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars
Lead Sponsor:
Galderma R&D
Conditions:
Acne Scars
Eligibility:
All Genders
18-50 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to assess the efficacy and safety of Adapalene Gel 0.3% in the treatment of atrophic acne scars.
Eligibility Criteria
Inclusion
- Male or female subjects of any race, aged 18 to 50 years inclusive
- Subjects with a past history of acne and with moderate to severe facial atrophic acne scars
Exclusion
- Subjects with active inflammatory acne lesions
- Subjects with hypertrophic acne scars
Key Trial Info
Start Date :
March 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01213199
Start Date
March 1 2011
End Date
September 1 2012
Last Update
February 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manisha PATEL
Baltimore, Maryland, United States, 21231